These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34311054)

  • 1. Informative censoring due to missing data in quality of life was inadequately assessed in most oncology randomized controlled trials.
    Olivier T; Haslam A; Prasad V
    J Clin Epidemiol; 2021 Nov; 139():80-86. PubMed ID: 34311054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is financial toxicity captured in quality of life assessments in oncology randomized clinical trials?
    Olivier T; Haslam A; Prasad V
    J Cancer Policy; 2023 Jun; 36():100423. PubMed ID: 37075841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
    Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M
    Ann Oncol; 2018 Dec; 29(12):2288-2295. PubMed ID: 30304498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Experience Captured by Quality-of-Life Measurement in Oncology Clinical Trials.
    Haslam A; Herrera-Perez D; Gill J; Prasad V
    JAMA Netw Open; 2020 Mar; 3(3):e200363. PubMed ID: 32129865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Reporting in Oncology Randomized Controlled Trials: From 2011 to 2015.
    Zhu H; Chen S; Xie P; Yang G; Zhong Z; Zhang H; Du Y
    Cancer Control; 2018; 25(1):1073274818781309. PubMed ID: 29895186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G).
    Smith AB; Cocks K; Parry D; Taylor M
    Qual Life Res; 2014 Apr; 23(3):971-6. PubMed ID: 24097080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting and dealing with missing quality of life data in RCTs: has the picture changed in the last decade?
    Fielding S; Ogbuagu A; Sivasubramaniam S; MacLennan G; Ramsay CR
    Qual Life Res; 2016 Dec; 25(12):2977-2983. PubMed ID: 27650288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review.
    Ter Veer E; van Kleef JJ; Sprangers MAG; Haj Mohammad N; van Oijen MGH; van Laarhoven HWM
    Gastric Cancer; 2018 Mar; 21(2):183-195. PubMed ID: 29380191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misleading Reporting (Spin) in Noninferiority Randomized Clinical Trials in Oncology With Statistically Not Significant Results: A Systematic Review.
    Ito C; Hashimoto A; Uemura K; Oba K
    JAMA Netw Open; 2021 Dec; 4(12):e2135765. PubMed ID: 34874407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve.
    Wilson MK; Friedlander ML; Joly F; Oza AM
    Oncologist; 2018 Feb; 23(2):203-213. PubMed ID: 29118265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy.
    Bylicki O; Gan HK; Joly F; Maillet D; You B; Péron J
    Ann Oncol; 2015 Jan; 26(1):231-237. PubMed ID: 25355720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial.
    Moinpour CM; Sawyers Triplett J; McKnight B; Lovato LC; Upchurch C; Leichman CG; Muggia FM; Tanaka L; James WA; Lennard M; Meyskens FL
    Psychooncology; 2000; 9(4):340-54. PubMed ID: 10960931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Censored patients in Kaplan-Meier plots of cancer drugs: An empirical analysis of data sharing.
    Rosen K; Prasad V; Chen EY
    Eur J Cancer; 2020 Dec; 141():152-161. PubMed ID: 33160265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literature.
    Rombach I; Rivero-Arias O; Gray AM; Jenkinson C; Burke Ó
    Qual Life Res; 2016 Jul; 25(7):1613-23. PubMed ID: 26821918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
    Pe M; Dorme L; Coens C; Basch E; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Dirven L; Dueck AC; Devlin N; Flechtner HH; Gotay C; Griebsch I; Groenvold M; King M; Koller M; Malone DC; Martinelli F; Mitchell SA; Musoro JZ; Oliver K; Piault-Louis E; Piccart M; Pimentel FL; Quinten C; Reijneveld JC; Sloan J; Velikova G; Bottomley A;
    Lancet Oncol; 2018 Sep; 19(9):e459-e469. PubMed ID: 30191850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-progression treatment in cancer randomized trials: a cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020.
    Olivier T; Haslam A; Prasad V
    BMC Cancer; 2023 May; 23(1):448. PubMed ID: 37198564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatments.
    Notarnicola S; Zumstein L; Paparo J; Marandino L; Perrone F; Di Maio M
    Eur J Cancer; 2023 Dec; 195():113374. PubMed ID: 38557561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018.
    Lombardi P; Marandino L; De Luca E; Zichi C; Reale ML; Pignataro D; Di Stefano RF; Ghisoni E; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Leone F; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
    Crit Rev Oncol Hematol; 2020 Feb; 146():102877. PubMed ID: 31981880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in oncology trials: a clinical guide.
    Movsas B
    Semin Radiat Oncol; 2003 Jul; 13(3):235-47. PubMed ID: 12903013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.